# Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)

> **NCT05813275** · PHASE3 · COMPLETED · sponsor: **Apnimed** · enrollment: 646 (actual)

## Conditions studied

- OSA

## Interventions

- **DRUG:** AD109
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05813275
- **Lead sponsor:** Apnimed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-16
- **Primary completion:** 2025-03-10
- **Final completion:** 2025-03-14
- **Target enrollment:** 646 (ACTUAL)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05813275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05813275, "Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05813275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*